α1D/A‐adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: Efficacy of dose increase therapy
α1D/A‐adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: Efficacy of dose increase therapy
复制标题
α1D/A-肾上腺素受体拮抗剂萘哌地尔治疗良性前列腺增生相关男性下尿路症状：剂量增加治疗的疗效
DOI：
--
复制
发表时间：
2013
影响因子：
2.6
通讯作者：
H. Kakizaki
中科院分区：
文献类型：
--
作者：
S. Yamaguchi;Hiroaki Osanai;A. Numata;Masaki Watanabe;H. Kakizaki
检查剂量增加治疗对50 mg/天萘哌地尔应答较差的良性前列腺增生相关下尿路症状患者的疗效。
To examine the efficacy of dose increase therapy in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia who responded poorly to 50 mg/day of naftopidil.
影响因子：
6.6
作者：
Jacobsen, SJ;Jacobson, DJ;Lieber, MM
通讯作者：
Lieber, MM